| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 11/11/2010 | US20100287630 Models for vaccine assessment |
| 11/11/2010 | US20100287629 Transgenic Non-Human Animals For Producing Chimeric Antibodies |
| 11/11/2010 | US20100287625 Vegf variants |
| 11/11/2010 | US20100286384 Replikin peptides in rapid replication of glioma cells and in influenza epidemics |
| 11/11/2010 | US20100286381 Diagnostic method for cancer characterized in the detection of the deletion of g-csf exon 3 |
| 11/11/2010 | US20100286375 Carrier molecules |
| 11/11/2010 | US20100286374 Method for making antibody fc-heterodimeric molecules using electrostatic steering effects |
| 11/11/2010 | US20100286373 Immunoglobulin affinity ligand |
| 11/11/2010 | US20100286369 Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
| 11/11/2010 | US20100286367 Conjugates of soluble peptidic compounds with membrane-binding agents |
| 11/11/2010 | US20100286362 Mammalian MDM2 Binding Proteins and Uses Thereof |
| 11/11/2010 | US20100286070 Affinity tag |
| 11/11/2010 | US20100286068 Molecular markers of plant embryogenesis |
| 11/11/2010 | US20100286060 Specific binding agents of human angiopoeitin-2 |
| 11/11/2010 | US20100286049 Polycystic kidney disease-related gene and use thereof |
| 11/11/2010 | US20100285995 Identification and Characterization of Pregnancy-Associated Genetic Signatures and Use Thereof for Diagnosis and Treatment of Breast Cancer |
| 11/11/2010 | US20100285570 Fluoride processing method |
| 11/11/2010 | US20100285564 Anticalins |
| 11/11/2010 | US20100285531 Therapeutic and Diagnostic Methods and Compositions Targeting 4Ig-B7-H3 and its Counterpart NK Cell Receptor |
| 11/11/2010 | US20100285529 Feline granulocyte macrophage colony stimulating factor proteins |
| 11/11/2010 | US20100285526 Compositions and Methods for Fusion Protein Separation |
| 11/11/2010 | US20100285508 Use of the protein em6 as a performance marker for germination of seed lots and applications thereof |
| 11/11/2010 | US20100285507 Plasma kallikrein fragments as diagnostic biomarkers for lung cancers |
| 11/11/2010 | US20100285506 Immunodetection assay for mycobacterium tuberculosis complex |
| 11/11/2010 | US20100285504 Monoclonal antibody which binds met in formalin-fixed and paraffin-embedded tissues and related methods |
| 11/11/2010 | US20100285500 Neurofurans-indices of oxidant stress |
| 11/11/2010 | US20100285497 Markers of endothelial cells and uses thereof |
| 11/11/2010 | US20100285466 Esophageal cancer markers |
| 11/11/2010 | US20100285452 Molecular Markers for the Diagnosis and Treatment of Tumors |
| 11/11/2010 | US20100285449 Human G-Protein Chemokine Receptor (CCR5) HDGNR10 |
| 11/11/2010 | US20100285052 Chemically Programmable Immunity |
| 11/11/2010 | US20100285049 Ex vivo animal or challenge model as method to measure protective immunity directed against parasites and vaccines shown to be protective in the method |
| 11/11/2010 | US20100285047 Therapeutics and diagnostics for group a streptococci |
| 11/11/2010 | US20100285045 Novel Neurotrophic Factor Protein and Uses Thereof |
| 11/11/2010 | US20100285037 Antibodies to cll-1 |
| 11/11/2010 | US20100285036 Anti-CD100 Neutralizing Antibodies and Methods of Using the Same |
| 11/11/2010 | US20100285035 High Affinity Antibody Antagonists of Interleukin-13 Receptor Alpha 1 |
| 11/11/2010 | US20100285034 Method |
| 11/11/2010 | US20100285030 Antibodies to Ox-2/Cd200 and Uses Thereof |
| 11/11/2010 | US20100285029 Treatment of fungal infections with polyene or beta glucan synthase inhibitor anti-fungals combined with anti-hsp90 antibodies |
| 11/11/2010 | US20100285027 Antibodies specific for human hepcidin |
| 11/11/2010 | US20100285025 Antibodies specific for the c-terminal regulatory domain of egfr and their use |
| 11/11/2010 | US20100285022 Anti-rsv g protein antibodies |
| 11/11/2010 | US20100285021 antihemophilic factor monoclonal antibodies comprising an immunoglobulin heavy chain and light chain amino acid sequences, with modified by enzymatic deglycosylation or by site directed mutagenesis, used for treating hemostasis disorders; anticoagulants |
| 11/11/2010 | US20100285019 Anti-IL-17F Antibodies and Methods of Use Thereof |
| 11/11/2010 | US20100285018 Estrogen receptors and methods of use |
| 11/11/2010 | US20100285017 Matriptase protein and uses thereof |
| 11/11/2010 | US20100285016 PRO34128 nucleic acids |
| 11/11/2010 | US20100285015 Targeting recombinant therapeutics to circulating red blood cells |
| 11/11/2010 | US20100285014 Immunoglobulin fusion proteins |
| 11/11/2010 | US20100285009 Humanized anti-egfl7 antibodies and methods using same |
| 11/11/2010 | US20100285007 Differential diagnosis of b-cell chronic lymphocytic leukemia |
| 11/11/2010 | US20100285005 Anti-cxcr4 antibodies |
| 11/11/2010 | US20100285004 Anti-CD38 human antibodies and uses thereof |
| 11/11/2010 | US20100284958 BoNT/A Peptides and Methods of Predicting and Reducing Immunoresistance to Botulinum Toxin Therapy |
| 11/11/2010 | US20100284920 Uses of monoclonal antibody 8h9 |
| 11/11/2010 | US20100284916 Antibodies Against Human Cytomegalovirus (HCMV) |
| 11/11/2010 | US20100284913 Methods and compositions for studying, imaging, and treating pain |
| 11/11/2010 | US20100284910 Novel Method of Diagnosing, Monitoring, Staging, Imaging and Treating Various Cancers |
| 11/11/2010 | US20100284909 Immunotherapy targeting of the shared abnormal conformational state of amyloidogenic peptides/proteins |
| 11/11/2010 | US20100284906 Internalizing Anti-CD74 Antibodies and Methods of Use |
| 11/11/2010 | CA2838400A1 Humanized anti-egfl7 antibodies and methods using same |
| 11/11/2010 | CA2761310A1 Antibodies and methods of use thereof |
| 11/11/2010 | CA2761203A1 Antibodies against nerve growth factor (ngf) with enhanced in vivo stability |
| 11/11/2010 | CA2760980A1 Novel monoclonal antibody for analyzing high-molecular weight adiponectin and utilization of same |
| 11/11/2010 | CA2760890A1 Anti-cd100 antibodies and methods for using the same |
| 11/11/2010 | CA2760755A1 Treatment for multiple sclerosis |
| 11/11/2010 | CA2760246A1 Humanized anti-egfl7 antibodies and methods using same |
| 11/11/2010 | CA2760239A1 Polypeptide derived from enterococcus and its use for vaccination |
| 11/11/2010 | CA2760185A1 Stable high protein concentration formulations of human anti-tnf-alpha antibodies |
| 11/11/2010 | CA2760064A1 Biomarker antibody and diagnosis device for detecting certain autoimmune diseases |
| 11/11/2010 | CA2759848A1 Anti-il-17f antibodies and methods of use thereof |
| 11/11/2010 | CA2759078A1 Compositions and methods of use for binding molecules to dickkopf-1 or dickkopf-4 or both |
| 11/11/2010 | CA2758994A1 Antibodies that recognize sulphatides and sulphated proteoglycans and the use thereof |
| 11/10/2010 | EP2248910A1 Epitope synchronization in antigen presenting cells |
| 11/10/2010 | EP2248899A1 NOGO receptor binding protein |
| 11/10/2010 | EP2248892A2 Fusion constructs and use of same to produce antibodies with increased FC receptor binding affinity and effector function |
| 11/10/2010 | EP2248831A1 Glycosylated antibodies |
| 11/10/2010 | EP2248830A1 Use of antagonist anti-CD40 antibodies for treatment of autoimmune and inflammatory diseases and organ transplant rejection |
| 11/10/2010 | EP2248829A1 Treatment with anti-VEGF antibodies |
| 11/10/2010 | EP2248828A1 Method for treating inflammation |
| 11/10/2010 | EP2248827A1 NOGO-A binding molecules with enhanced affinity and pharmaceutical use thereof |
| 11/10/2010 | EP2248826A1 Antibody directed against pcrv |
| 11/10/2010 | EP2248825A1 Antigen binding fragments of an antibody for use in treating and diagnosing ocular diseases |
| 11/10/2010 | EP2248533A1 Polypeptide derived from enterococcus and its use for vaccination |
| 11/10/2010 | EP2248529A1 Modulation of NKG2D |
| 11/10/2010 | EP2247621A1 Monospecific antibody and method of production using as antigen an isoform of the human fad synthetase. |
| 11/10/2010 | EP2247620A1 Anti-cd79b antibodies and immunoconjugates and methods of use |
| 11/10/2010 | EP2247619A1 Humanized anti-human nkg2a monoclonal antibody |
| 11/10/2010 | EP2247618A1 Ferroportin antibodies and methods of use |
| 11/10/2010 | EP2247617A2 Methods and compositions for targeting polyubiquitin |
| 11/10/2010 | EP2247616A2 Novel antigen binding dimer-complexes, methods of making and uses thereof |
| 11/10/2010 | EP2247612A1 Siva 3, its preparation and use |
| 11/10/2010 | EP2247312A2 Compositions and methods for the treatment of tumor of hematopoietic origin |
| 11/10/2010 | EP2247310A1 Compositions and methods for crystallizing antibody fragments |
| 11/10/2010 | EP2247305A1 Stabilized angiopoietin-2 antibodies and uses thereof |
| 11/10/2010 | EP2247304A2 Her2/neu-specific antibodies and methods of using same |
| 11/10/2010 | EP1265915B1 Novel compounds |
| 11/10/2010 | EP1015477B1 32 Human secreted proteins |
| 11/10/2010 | EP0958362B1 Isolation and use of motoneuronotrophic factors |